GenMark Diagnostics, Inc. (GNMK)
-NasdaqGM 9.57 
1.40(12.76%) 4:00PM EDT|After Hours
:
9.44 0.13 (1.36%) 4:55PM EDT
| Prev Close: | 10.97 |
|---|
| Open: | 10.50 |
|---|
| Bid: | 9.25 x 1500 |
|---|
| Ask: | 9.57 x 400 |
|---|
| 1y Target Est: | 16.10 |
|---|
| Beta: | 0.57 |
|---|
| Next Earnings Date: | 7-Aug-13 |
|---|
| Day's Range: | 9.51 - 10.68 |
|---|
| 52wk Range: | 4.02 - 16.00 |
|---|
| Volume: | 1,863,194 |
|---|
| Avg Vol (3m): | 257,767 |
|---|
| Market Cap: | 313.61M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Nasdaq stocks posting largest percentage decreasesAP(Tue 6:04PM EDT)
- Why GenMark Diagnostics Shares Slumpedat Motley Fool(Tue 1:26PM EDT)
- On The Fly: Midday Wrapat theflyonthewall.com(Tue 12:21PM EDT)
- Stocks to Watch: GenMark, Sony, Hormel Foodsat The Wall Street Journal(Tue 9:13AM EDT)
- Sony advances on Loeb agitationoptionMONSTER(Tue 8:27AM EDT)
- GenMark shares likely to continue trading lower, says William Blairat theflyonthewall.com(Tue 7:24AM EDT)
- GenMark Diagnostics' CEO Hosts Annual Revenue Guidance Update Conference (Transcript)at Seeking Alpha(Mon, Jun 17)
- GenMark slides after-hours on revenue cutat MarketWatch(Mon, Jun 17)
- After-Hours Buzz: Korn/Ferry, Host Hotels, Campbell Soup & Moreat CNBC(Mon, Jun 17)
- GenMark expects to grow 50% YoY, despite revenue uncertaintiestheflyonthewall.com(Mon, Jun 17)
- InPlay: GenMark Diagnostics sees FY13 revenues of approx $30 mln compared to prior guidance of $35 mlnBriefing.com(Mon, Jun 17)
- GenMark Diagnostics Updates Annual Revenue GuidanceBusiness Wire(Mon, Jun 17)
- GENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 17)
- [$$] Charting the Marketat Barrons.com(Sat, Jun 15)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Fri, Jun 14)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 12.22 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.79 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.23 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -0.51 |
|---|
Business Summary
GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the United States.
View More